Y-mAbs Names Peter Pfreundschuh as CFO
Monday, 1 July 2024, 20:14
CFO Appointment at Y-mAbs Therapeutics
Y-mAbs Therapeutics has named Peter Pfreundschuh as its new Chief Financial Officer (CFO), starting from June 28, 2024. Pfreundschuh is set to play a crucial role in overseeing the financial aspects of the company, with a focus on strategic planning and growth initiatives.
Key Points:
- Peter Pfreundschuh appointed as CFO of Y-mAbs Therapeutics
- Effective from June 28, 2024
- Expectations of strategic financial decision-making and enhancing growth trajectory
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.